Dendritic Cell Vaccines Offer Promising Signals as Glioblastoma Therapy
Immunotherapy is rapidly emerging as a very attractive and novel therapeutic approach for cancer, including for glioblastoma multiforme (GBM), the most common primary malignant brain tumor in adults.